ML15258A386

From kanterella
Revision as of 17:44, 20 June 2019 by StriderTol (talk | contribs) (Created page by program invented by StriderTol)
Jump to navigation Jump to search
Shine Medical Technologies V. 0 - Chapter 16 - Other License Considerations
ML15258A386
Person / Time
Site: SHINE Medical Technologies
Issue date: 08/27/2015
From: Bynum R
Shine Medical Technologies
To:
Office of Nuclear Reactor Regulation
Lynch S
References
SHINE, SHINE.SUBMISSION.22, SHN.PSAR.P, SHN.PSAR.P.10
Download: ML15258A386 (6)


Text

Chapter 16 - Other License ConsiderationsTable of ContentsSHINE Medical Technologies16-iRev. 0CHAPTER 16OTHER LICENSE CONSIDERATIONSTable of Contents SectionTitle Page16.1PRIOR USE OF FACILITY COMPONENTS...................................................16-116.2MEDICAL USE OF THE FACILITY.................................................................16-2 Chapter 16 - Other License ConsiderationsList of TablesSHINE Medical Technologies 16-ii Rev. 0List of Tables NumberTitle None Chapter 16 - Other License ConsiderationsList of FiguresSHINE Medical Technologies16-iii Rev. 0List of Figures NumberTitle None Chapter 16 - Other License ConsiderationsAcronyms and AbbreviationsSHINE Medical Technologies16-ivRev. 0Acronyms and AbbreviationsAcronym/Abbreviation Definition SHINESHINE Medical Technologies, Inc.

Chapter 16 - Other License ConsiderationsPrior Use of Facility ComponentsSHINE Medical Technologies16-1Rev. 0CHAPTER 16OTHER LICENSE CONSIDERATIONS16.1PRIOR USE OF FACILITY COMPONENTSThe SHINE Medical Technologies, Inc. (SHINE) facility utilizes new and appropriately-qualified components and systems to conduct production operations. Discussions regarding used components and systems are not applicable to the SHINE facility.

Chapter 16 - Other License ConsiderationsMedical Use of the FacilitySHINE Medical Technologies16-2Rev. 016.2MEDICAL USE OF THE FACILITYThe SHINE facility does not contain equipment or facilities associated with direct medical administration of radioisotopes or other radiation-based therapies. Therefore, discussions involving medical use of the SHINE facility are not applicable.